- Home
- EQH vs TECH Comparison
EQH vs TECH Comparison
Compare EQH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- TECH
- Stock Information
- Founded
- EQH 1859
- TECH 1976
- Country
- EQH United States
- TECH United States
- Employees
- EQH N/A
- TECH N/A
- Industry
- EQH Specialty Insurers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQH Finance
- TECH Health Care
- Exchange
- EQH Nasdaq
- TECH Nasdaq
- Market Cap
- EQH N/A
- TECH 8.0B
- IPO Year
- EQH N/A
- TECH 1989
- Fundamental
- Price
- EQH $50.05
- TECH $50.78
- Analyst Decision
- EQH Buy
- TECH Buy
- Analyst Count
- EQH 11
- TECH 8
- Target Price
- EQH $60.00
- TECH $81.14
- AVG Volume (30 Days)
- EQH 3.3M
- TECH 2.3M
- Earning Date
- EQH 04-29-2025
- TECH 05-07-2025
- Dividend Yield
- EQH 1.91%
- TECH 0.63%
- EPS Growth
- EQH 8.62
- TECH N/A
- EPS
- EQH 3.78
- TECH 0.98
- Revenue
- EQH $12,759,000,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- EQH $25.90
- TECH $8.19
- Revenue Next Year
- EQH $1.89
- TECH $8.85
- P/E Ratio
- EQH $13.27
- TECH $51.85
- Revenue Growth
- EQH 21.33
- TECH 4.46
- 52 Week Low
- EQH $36.46
- TECH $46.44
- 52 Week High
- EQH $56.00
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- EQH 52.72
- TECH 42.06
- Support Level
- EQH $45.10
- TECH $46.01
- Resistance Level
- EQH $50.89
- TECH $53.54
- Average True Range (ATR)
- EQH 2.88
- TECH 3.36
- MACD
- EQH 0.33
- TECH 0.19
- Stochastic Oscillator
- EQH 91.16
- TECH 57.33
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.